Autoimmune Lymphoproliferative Syndrome (ALPS) with Recurrent Viral Infections

Another names
Types
Causes
Symptoms
Diagnostic tests
Non-Pharmacological Treatments (Therapies & Others)
Drug Treatments
Dietary Molecular Supplements
Immunity-Booster / Regenerative / Stem-Cell” Therapies
Surgeries / Procedures
Prevention Tips
When to See a Doctor Urgently
What to Eat and What to Avoid
Frequently Asked Questions

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic immune system disease where old or damaged immune cells do not die when they should. Because these cells do not die, they build up in the body and make the lymph nodes, spleen, and sometimes the liver big. Many patients also get autoimmune problems that destroy their own blood cells, such as anemia (low red cells), low platelets, or low neutrophils. Children usually show symptoms early in life. People with ALPS may also have a higher risk of lymphoma later on. The main cause is a change (mutation) in the FAS pathway (often the FAS gene), which controls normal immune-cell death. Recurrent viral infections, like repeated or hard-to-clear Epstein–Barr virus (EBV), can happen because the immune system is unbalanced and crowded with the wrong kinds of T cells, making infection control less effective. PMC+4PMC+4NCBI+4

In a healthy body, immune cells grow, fight germs, and then die at the right time. The FAS pathway is one of the key “off switches” that tells used immune cells to die. In ALPS, changes in FAS (or related genes like FASL, CASP10) break this off switch. As a result, special T cells called “double-negative T cells” (DNTs) build up. These cells and other immune signals push the immune system to attack the body’s own blood cells and to make lymph nodes and the spleen big. This same failure can also make it harder to control some viruses (for example, EBV), and over many years it can raise the risk of lymphoma. Frontiers+3NCBI+3PMC+3

Autoimmune lymphoproliferative syndrome (ALPS) is a rare, inherited problem of the immune system in which certain white blood cells (lymphocytes) do not die when they should. Because these cells “refuse” to switch off, they build up in the body and make the lymph nodes, spleen, and sometimes the liver get bigger. The same immune cells can also mistakenly attack the person’s own blood cells, causing anemia, low platelets, or low neutrophils (these are called “autoimmune cytopenias”). Some people with ALPS also have recurrent viral infections, especially with common herpes-family viruses like Epstein–Barr virus (EBV) or cytomegalovirus (CMV). The basic reason is a fault in the “cell death” (apoptosis) pathway, most often involving the FAS signal. This pathway normally tells used or harmful lymphocytes to die. When it fails, too many abnormal T cells—especially a subset called double-negative T cells (they lack both CD4 and CD8 markers)—accumulate and misbehave. Over a lifetime, there is also a higher risk of lymphoma compared with the general population. PMC+3NCBI+3MedlinePlus+3

Importantly, recurrent viral infections are not universal in ALPS, but they can occur for several reasons: the underlying immune dysregulation; depletion of normal B cells or antibodies after certain treatments (e.g., rituximab); removal of the spleen in the past; or coinfections/viral reactivations such as EBV or CMV that “take advantage” of the disordered immune system. Frontiers+3PMC+3PMC+3

Another names

ALPS (autoimmune lymphoproliferative syndrome) ASH Publications
FAS-related ALPS (historically “ALPS-Ia”) when caused by FAS gene variants; somatic FAS ALPS when only some cells carry the variant NCBI
FASL-related ALPS (FASLG gene) and CASP10-related ALPS (caspase-10) NCBI
ALPS-U (ALPS of undetermined genetic cause) NCBI
ALPS-like disorders (conditions with very similar features): FADD deficiency, RAS-associated autoimmune leukoproliferative disease (RALD; NRAS/KRAS), and CASP8 deficiency (which classically gives combined immunodeficiency with infections but may overlap) PMC+1

Types

Doctors classify ALPS by the gene involved and by whether the variant is in all cells (germline) or only in some cells (somatic/mosaic):

ALPS-FAS (germline FAS variants): the most common form; classic ALPS picture. NCBI
ALPS-sFAS (somatic/mosaic FAS): only a subset of lymphocytes carry the FAS variant; can look identical clinically. NCBI
ALPS-FASLG: variants in FAS ligand (the “key” that turns on FAS). NCBI
ALPS-CASP10: variants in caspase-10, a downstream apoptosis enzyme. NCBI
ALPS-U (undetermined): clinical/lab features of ALPS but no gene found yet. NCBI
ALPS-like conditions:
- FADD deficiency (adaptor protein in apoptosis)
- RAS-associated autoimmune leukoproliferative disease (RALD) due to NRAS/KRAS variants
- CASP8 deficiency (immunodeficiency with recurrent infections; overlaps with lymphoproliferation)
  These sit in the broader umbrella of Inborn Errors of Immunity (IEI). PMC+2PMC+2

Causes

Below are root causes and risk amplifiers. Each item explains the “why” in plain English.

Germline FAS gene variants: break the main “self-destruct” signal in lymphocytes; cells that should die persist and cause lymph node/spleen enlargement and autoimmunity. NCBI
Somatic (mosaic) FAS variants: when only some immune cells carry the error; clinical picture can mirror classic ALPS. NCBI
FASLG (FAS ligand) variants: the “signal key” is faulty, so FAS cannot be triggered effectively. NCBI
CASP10 variants: block an enzyme that executes the cell-death program, again leading to cell build-up. NCBI
Defects in related apoptosis molecules (ALPS-like), e.g., FADD: the message to die is not passed along. PMC
CASP8 deficiency: not classic ALPS, but overlapping; causes immune dysregulation and recurrent infections because activation and death signals are both disturbed. PMC
RALD (NRAS/KRAS variants): causes chronic lymphocyte expansion and autoimmune blood problems that can mimic ALPS. PMC
Persistent EBV infection/reactivation: EBV infects B cells and can expand abnormal T cells; in ALPS the control is weaker, so recurrent or difficult EBV problems may appear. PMC
CMV infection/reactivation: CMV can be more severe or prolonged in patients with apoptosis defects. PMC
Hypogammaglobulinemia in some cases or after therapy (e.g., rituximab): fewer protective antibodies make viruses easier to catch. PMC
Splenectomy (historical practice): removing the spleen increases infection risk lifelong; modern guidance advises avoiding splenectomy when possible in ALPS. Frontiers+1
Intensive immunosuppression (e.g., rituximab): can increase viral complications in ALPS more than in other disorders; it’s now generally avoided or used last. PMC
Neutropenia (autoimmune): low neutrophils reduce the first-line defense against infections. NCBI
Chronic lymphadenopathy with abnormal “double-negative T cells” (DNTs): these cells are expanded and dysfunctional, which contributes to immune imbalance. PMC
Genetic mosaicism/variable penetrance: milder signals may delay diagnosis, allowing infections to recur before the root cause is found. NCBI
Coexisting inborn errors of immunity: some families may have more than one immune gene variant, compounding risk. (Inferred from IUIS series). PMC
Environmental viral exposure (household/school outbreaks): any immune imbalance increases the “take rate” of these common viruses; the baseline risk is amplified. (Public-health principle; contextualized by EBV/CMV reports in ALPS.) PMC+1
Delayed vaccinations or gaps in vaccine-induced protection (where appropriate vaccines exist), leaving more doors open to some viruses. (General principle in primary immunodeficiency education.) Primary Immune
Therapy-related lymphocyte redistribution (e.g., steroids): short-term benefit for autoimmunity, but can temporarily lower antiviral defenses. PMC
Evolving IEI landscape: new genes in the apoptosis/immune-regulation pathways continue to be recognized; some present with ALPS features plus infections. wp-iuis.s3.eu-west-1.amazonaws.com

Symptoms

Painless, persistently enlarged lymph nodes in the neck, armpits, or groin. NCBI+1
Big spleen (splenomegaly) and sometimes big liver (hepatomegaly). People may feel “full” early or have left-sided discomfort. NCBI
Recurrent fevers during viral episodes or autoimmune flares. Medscape
Easy bruising, nosebleeds, or petechiae from autoimmune low platelets (ITP). NCBI
Pallor, tiredness, shortness of breath from autoimmune hemolytic anemia (AIHA). NCBI
Frequent or prolonged viral infections (e.g., EBV/“mono”, CMV, shingles/HSV), sometimes more severe or lingering. PMC+1
Mouth ulcers or sore throat with swollen nodes. Medscape
Recurrent infections after certain treatments (e.g., rituximab) due to lowered antibodies. PMC
Abdominal discomfort from enlarged spleen or liver. NCBI
Night sweats or weight loss—important to evaluate because ALPS carries a lymphoma risk over time. NCBI
Skin rashes linked to autoimmune activity. Medscape
Bone pain or discomfort when marrow is “working overtime” during cytopenia recovery. Medscape
Frequent fatigue and reduced stamina from anemia or chronic inflammation. Medscape
Fullness after small meals from big spleen pressing on the stomach. NCBI
Occasional jaundice (yellow eyes/skin) during autoimmune red-cell destruction. NCBI

Diagnostic tests

A) Physical examination

Whole-body lymph node check: the doctor gently feels neck, armpits, and groin for enlarged nodes. Persistent, non-tender enlargement supports lymphoproliferation. NCBI
Liver and spleen size (palpation/percussion): helps document hepatosplenomegaly at the bedside; serial exams show trends over time. NCBI
Skin and mucosa inspection: looks for bruising, petechiae, pallor, jaundice, ulcers—clues to autoimmune cytopenias or infection. Medscape
Vital signs and growth parameters: fever curves and weight trends help separate infection flares from autoimmune flares. Medscape

B) “Manual” clinical assessments

Spleen tip measurement and serial node mapping: simple bedside tracking over visits; documents response to treatment. NCBI
Performance/energy scales (clinical scoring): practical way to track fatigue from anemia or chronic inflammation. Medscape
Bleeding assessment (nosebleed frequency, bruising diary): helps judge platelet autoimmunity impact and treatment need. NCBI

C) Laboratory and pathological tests

Complete blood count (CBC) with reticulocyte count: detects anemia, neutropenia, thrombocytopenia; retic count shows marrow response in hemolysis. NCBI
Direct antiglobulin (Coombs) test: confirms autoimmune hemolysis when positive. NCBI
Peripheral smear review: looks for hemolysis signs or atypical lymphocytes. Medscape
Flow cytometry for “double-negative T cells” (DNTs): hallmark increase in CD3+ TCRαβ+ CD4– CD8– cells supports ALPS. PMC+1
FAS pathway biomarkers: soluble FAS ligand (sFASL), IL-10, IL-18, vitamin B12 often elevated in ALPS and can support the diagnosis. NCBI
Apoptosis (FAS-induced cell-death) assay: functional test showing lymphocytes fail to die when FAS is triggered. ASH Publications
Viral studies during infections: EBV and CMV PCR/serology help confirm reactivation or primary infection driving fevers or cytopenia flares. PMC+1
Quantitative immunoglobulins and vaccine titers: screen for low antibodies (can be therapy-related) that raise infection risk. PMC
Genetic testing (targeted panels or exome): looks for variants in FAS, FASLG, CASP10, and ALPS-like genes (e.g., FADD, NRAS/KRAS, CASP8). Somatic mosaicism may require testing sorted cell subsets. NCBI+1

D) Imaging tests

Ultrasound of abdomen: safe way to measure spleen/liver size and watch changes over time. Medscape
Ultrasound of peripheral nodes: helps characterize nodes without radiation. Medscape
CT or MRI (selected cases): used when nodes are deep or when lymphoma is suspected; balances detail with radiation exposure (MRI avoids radiation). NCBI
PET-CT (selected cases): if there are “B” symptoms or fast-growing nodes; helps identify areas that might need biopsy to rule out lymphoma. NCBI

Note on electrodiagnostic tests: ALPS does not require nerve or muscle electrodiagnostic studies; diagnosis relies on clinical features, immunophenotyping, biomarkers, genetics, and imaging. I’m including this note because your requested template lists “Electrodiagnostic,” but in ALPS they are generally not applicable.

Non-Pharmacological Treatments (Therapies & Others)

(Each item includes description, purpose, and mechanism in simple words.)

Education & Care Plan
You and your family learn what ALPS is, what signs to watch, and how to act early if there is fever, bleeding, or severe tiredness. A written plan explains when to call the doctor, when to go to the hospital, and which medicines are safe or not. Purpose: safer day-to-day care. Mechanism: quick action reduces harm from infections or bleeding. Medscape
Infection-prevention habits
Frequent handwashing, masks during outbreaks, and staying away from sick contacts lower the chance of catching viruses and bacteria when immunity is off-balance. Purpose: fewer infections. Mechanism: cuts germ exposure at the source. Medscape
Vaccination review (with specialist)
Keep non-live vaccines up to date (pneumococcal, influenza, COVID-19). Avoid live vaccines while on significant immunosuppression. Purpose: prevent severe vaccine-preventable disease. Mechanism: trains the immune system safely. Decisions must be individualized by your hematology/immunology team. Medscape
Fever action plan
Have a thermometer, know your threshold for urgent care, and keep contacts for your doctor. Purpose: treat infections fast. Mechanism: early evaluation prevents complications. Medscape
Nutrition support
Balanced diet rich in protein, fruits, and vegetables supports healing and blood formation. If there is true deficiency (like iron, B12, folate), a clinician replaces it. Purpose: optimize blood counts and energy. Mechanism: supplies building blocks for healthy cells. Medscape
Dental and mouth care
Good brushing, flossing, and dental checks reduce mouth sores and infections that can be serious when white cells or platelets are low. Purpose: lower infection and bleeding risk. Mechanism: reduces bacterial load in the mouth. Medscape
Activity with pacing
Gentle daily activity helps energy and mood, but avoid contact sports when the spleen is large or platelets are low. Purpose: safe fitness. Mechanism: movement improves stamina without bleeding risk. Medscape
Splenic safety
If the spleen is enlarged, use seat belts correctly, avoid abdominal trauma, and seek care after any blow to the left upper abdomen. Purpose: prevent splenic rupture. Mechanism: reduces mechanical injury. Medscape
Sun and skin care
Protect skin if rashes or vasculitis occur. Purpose: reduce flares and infections through broken skin. Mechanism: barrier protection lowers inflammation and germs. Genetic & Rare Diseases Info Center
Psychosocial support
Counseling, school accommodations, and peer groups lower stress, improve adherence, and support family well-being. Purpose: better quality of life. Mechanism: mental health support improves outcomes. Medscape
Environmental hygiene
Clean high-touch surfaces and use safe food handling. Purpose: fewer gastrointestinal and respiratory infections. Mechanism: lowers pathogen exposure. Medscape
Travel planning
Carry medical summaries and know where to get urgent care; update vaccines before travel. Purpose: safe travel. Mechanism: rapid access to care reduces risk. Medscape
Genetic counseling
Explains inheritance, family testing, and reproductive options. Purpose: informed family decisions. Mechanism: clarifies FAS-pathway genetics. NCBI
School/work communication
Provide written plans for teachers/employers about fatigue, infection risk, or clinic visits. Purpose: safety and flexibility. Mechanism: reduces exposure and stress. Medscape
Home thermometer & oximeter
Monitor fever and oxygen during respiratory infections. Purpose: earlier triage. Mechanism: objective data prompts timely care. Medscape
All-medications list & alerts
Keep a current list, especially if on immune-modifying drugs. Purpose: prevents interactions. Mechanism: coordinated care among providers. Medscape
Bone health basics
If you use steroids at times, ensure calcium, vitamin D, and weight-bearing activity per clinician advice. Purpose: protect bones. Mechanism: supports bone remodeling. Medscape
Bleeding precautions
Soft toothbrush, electric razor; avoid NSAIDs if platelets are low unless doctor approves. Purpose: lower bleeding risk. Mechanism: protects fragile mucosa. Medscape
Infection “shielding” during outbreaks
Temporarily reduce crowded indoor time when community viral rates spike. Purpose: avoid triggers. Mechanism: less exposure = fewer infections. Medscape
Regular specialist follow-up
Hematology/immunology visits to track lymph nodes, spleen size, blood counts, and lymphoma risk over time. Purpose: early detection and treatment. Mechanism: ongoing monitoring improves outcomes. PMC+1

Drug Treatments

Prednisone / Prednisolone (corticosteroid)
Class: Glucocorticoid. Dose/Time: Short courses for flares; taper as advised. Purpose: Quickly control autoimmune cytopenias and inflammation. Mechanism: Broad anti-inflammatory and immunosuppressive action. Side effects: High sugar, mood changes, infection risk, bone thinning with long use. Medscape
Sirolimus (rapamycin; mTOR inhibitor)
Class: mTOR inhibitor. Dose/Time: Oral daily under level monitoring. Purpose: Treats cytopenias and lymphoproliferation; often effective when steroids fail. Mechanism: Targets activated T cells and abnormal double-negative T cells central to ALPS biology. Side effects: Mouth sores, high lipids, infection risk; requires monitoring. PMC+1
Mycophenolate mofetil (MMF)
Class: Antimetabolite immunosuppressant. Dose/Time: Oral twice daily; specialist-set dose. Purpose: Steroid-sparing control of autoimmune cytopenias. Mechanism: Inhibits lymphocyte proliferation by blocking purine synthesis. Side effects: GI upset, low white cells, infection risk. Evidence: Good responses reported in ALPS cohorts. PubMed
Rituximab
Class: Anti-CD20 monoclonal antibody. Dose/Time: IV cycles for refractory immune thrombocytopenia or hemolytic anemia. Purpose: Depletes B cells making harmful antibodies. Mechanism: Targets CD20 on B cells. Side effects: Infusion reactions, infection risk, hypogammaglobulinemia. Medscape
IVIG (intravenous immunoglobulin)
Class: Pooled antibodies. Dose/Time: IV intermittently for cytopenias or antibody support. Purpose: Blocks harmful autoantibodies and supports immunity. Mechanism: Immune modulation via Fc-receptor blockade and anti-idiotype effects. Side effects: Headache, aseptic meningitis, thrombosis risk (rare). Medscape
Azathioprine
Class: Antimetabolite immunosuppressant. Dose/Time: Daily with TPMT/NUDT15 safety checks. Purpose: Second-line steroid-sparing option. Mechanism: Purine analog reducing lymphocyte proliferation. Side effects: Myelosuppression, liver toxicity, infections. Medscape
Cyclophosphamide (select cases)
Class: Alkylating agent. Dose/Time: Pulses in severe refractory autoimmunity (specialist use). Purpose: Rescue therapy. Mechanism: Broad cytotoxic immune suppression. Side effects: Low counts, infertility risk, infections, bladder toxicity. Medscape
Cyclosporine
Class: Calcineurin inhibitor. Dose/Time: Level-guided daily dosing. Purpose: Alternative immune modulation. Mechanism: Blocks T-cell activation via calcineurin. Side effects: Kidney toxicity, hypertension, tremor. Medscape
Tacrolimus
Class: Calcineurin inhibitor. Dose/Time: Level-guided daily dosing. Purpose: Similar to cyclosporine where appropriate. Mechanism: Inhibits T-cell activation. Side effects: Kidney toxicity, neurotoxicity, diabetes risk. Medscape
Hydroxychloroquine (selected inflammatory features)
Class: Antimalarial with immunomodulation. Dose/Time: Daily; eye checks needed. Purpose: Helps some autoimmune symptoms. Mechanism: Interferes with antigen processing and TLR signaling. Side effects: Retinopathy risk, GI upset. Medscape
G-CSF (filgrastim) for neutropenia
Class: Hematopoietic growth factor. Dose/Time: Intermittent injections as directed. Purpose: Raise neutrophils to reduce infection risk. Mechanism: Stimulates marrow neutrophil production. Side effects: Bone pain, spleen enlargement (monitor). Medscape
Eltrombopag or Romiplostim (for severe ITP pattern)
Class: Thrombopoietin receptor agonists. Dose/Time: Oral (eltrombopag) or weekly injection (romiplostim). Purpose: Raise platelets in refractory thrombocytopenia. Mechanism: Stimulates platelet production. Side effects: Liver tests changes (eltrombopag), thrombosis risk. Medscape
Antiviral therapy during proven viral illnesses (case-by-case)
Class: Antivirals (e.g., acyclovir for HSV/VZV). Purpose: Treat specific viral infections promptly. Mechanism: Blocks viral replication. Side effects: Drug-specific; renal monitoring for some agents. Use is targeted, not chronic. Medscape
Antibiotics for bacterial infections (as needed)
Class: Antibacterials. Purpose: Early treatment of confirmed/suspected bacterial infection. Mechanism: Kills or stops bacteria. Side effects: Drug-specific; watch C. difficile risk. Medscape
Pneumocystis prophylaxis in select patients on heavy immunosuppression
Class: TMP-SMX or alternatives. Purpose: Prevent serious opportunistic pneumonia. Mechanism: Inhibits folate pathway in Pneumocystis. Side effects: Rash, cytopenias (monitor). Medscape
Ruxolitinib (research/selected refractory cases)
Class: JAK inhibitor. Purpose: Off-label in immune dysregulation; specialist decision. Mechanism: Dampens cytokine signaling. Side effects: Cytopenias, infection risk. Medscape
Belimumab (rare/select)
Class: Anti-BAFF monoclonal antibody. Purpose: For B-cell–driven autoimmunity patterns in complex cases. Mechanism: Lowers B-cell survival signals. Side effects: Infection risk. Medscape
Abatacept (select refractory autoimmunity)
Class: CTLA-4–Ig fusion. Purpose: T-cell co-stimulation blockade. Mechanism: Prevents full T-cell activation. Side effects: Infection risk. Medscape
Short-course high-dose IV steroids for hemolysis crises
Class: Glucocorticoid (pulse). Purpose: Rapid rescue. Mechanism: Strong immune suppression quickly. Side effects: As above; monitor closely. Medscape
Transition to sirolimus or MMF as steroid-sparing maintenance
Class: mTOR inhibitor or antimetabolite. Purpose: Long-term control with fewer steroid side effects. Mechanism: Targeted immune modulation aligned to ALPS biology. Side effects: As above; lab monitoring needed. Evidence: Multiple series show strong responses, especially with sirolimus. PMC+1

Dietary Molecular Supplements

(Use only with clinician approval; treat nutrient deficiencies if present.)

Vitamin D
Dose: Per blood level/doctor advice. Function/Mechanism: Supports immune balance and bone health, important if steroids are used. Medscape
Folate (B9)
Dose: Replace only if deficient. Function: Needed for red blood cell production; may help anemia due to deficiency, not autoimmune hemolysis. Medscape
Vitamin B12
Dose: Guided by lab results. Function: Supports red blood cell and nerve health; correct true deficiency. Medscape
Iron
Dose: Only if iron-deficiency is proven. Function: Rebuilds hemoglobin in iron-deficiency anemia; not for hemolysis alone. Medscape
Omega-3 fatty acids
Dose: Typical food-based intake or supplements per clinician advice. Function: Mild anti-inflammatory effects that may help general inflammation. Medscape
Zinc (short-term if low)
Dose: Avoid excess. Function: Helps normal immune function when truly deficient. Medscape
Vitamin C (diet-first)
Dose: Food-based; supplement if intake is low. Function: Antioxidant support and wound healing; not a treatment for ALPS itself. Medscape
Probiotics (case-by-case)
Dose: Choose products with safety data; avoid in profound neutropenia unless approved. Function: Gut-immune crosstalk; may support GI health. Medscape
Protein-rich foods / essential amino acids
Dose: Dietitian-guided intake. Function: Supports marrow production and healing. Medscape
Multivitamin (low-dose)
Dose: Standard daily if diet is limited. Function: Covers small gaps; not disease-specific therapy. Medscape

Immunity-Booster / Regenerative / Stem-Cell” Therapies

IVIG (passive antibodies)
Dose: Intermittent IV. Function/Mechanism: Provides pooled antibodies and modulates immunity when your own antibodies are low or harmful. Medscape
G-CSF (filgrastim)
Dose: Intermittent injections. Function: “Boosts” neutrophil counts to fight infections when neutropenia is present. Medscape
Thrombopoietin receptor agonists (eltrombopag/romiplostim)
Dose: As directed. Function: Stimulate platelet production in severe thrombocytopenia. Medscape
Sirolimus (immune re-balancer)
Dose: Daily with levels. Function: Targets overactive/abnormal T-cell signals and DNT cells central to ALPS. PMC
Mycophenolate (immune modulator)
Dose: Twice daily. Function: Reduces antibody-mediated blood cell destruction by limiting lymphocyte growth. PubMed
Hematopoietic Stem Cell Transplant (HSCT)
Dose: Procedure, not a pill; considered only for very severe, refractory disease. Function: Replaces the faulty immune system with a donor’s healthy system; carries serious risks, so reserved for select cases. Medscape

Surgeries / Procedures

Diagnostic lymph node biopsy
What happens: A surgeon removes a lymph node to examine it. Why: Rule out lymphoma or other diseases when nodes are very large or unusual. Medscape
Splenectomy (generally avoided today)
What happens: Removal of the spleen. Why: Historically used for severe cytopenias; now avoided if possible due to lifelong infection risk. Only considered after modern medical options fail. Medscape
Port/central line placement
What happens: A small device is placed for safe repeated IV medicines. Why: Needed if frequent IVIG or other infusions are required. Medscape
Bone marrow examination
What happens: Needle sample from hip bone. Why: Clarify causes of low counts and exclude other marrow diseases. Medscape
Hematopoietic Stem Cell Transplant (HSCT)
What happens: Conditioning chemo, then donor stem cells. Why: Last-resort for severe, refractory ALPS; can cure immune defect but carries significant risks (infection, graft-versus-host disease). Medscape

Prevention Tips

Keep vaccinations current (non-live; avoid live if immunosuppressed) per specialist plan. Medscape
Wash hands often; mask during outbreaks; avoid close contact with sick people. Medscape
Have a fever plan and act early for temperatures per your doctor’s advice. Medscape
See your specialist regularly to monitor lymph nodes, spleen, and blood counts. PMC
Protect an enlarged spleen from trauma; avoid contact sports if platelets are low. Medscape
Maintain good mouth and dental care to lower infection risk. Medscape
Use your medicines exactly as prescribed; keep a current medication list. Medscape
Plan travel with medical summaries and local care locations. Medscape
Eat a balanced diet; correct true nutrient deficiencies. Medscape
Learn lymphoma warning signs (rapid node growth, night sweats, weight loss) and seek care quickly. PMC

When to See a Doctor Urgently

Go now (ER or urgent clinic) for: high fever or shaking chills; shortness of breath; confusion; severe weakness; fast, large bruises or nose/gum bleeding that will not stop; very dark urine or yellow eyes (possible hemolysis); severe belly pain on the left (spleen) or after trauma; very fast growth of lymph nodes or night sweats with weight loss. Early care prevents serious complications. Medscape+1

What to Eat and What to Avoid

Eat a balanced plate with lean protein, whole grains, fruits, and vegetables. Drink enough water. If you have low neutrophils, follow food-safety rules (well-cooked meats/eggs, careful washing of produce). If platelets are low, avoid alcohol and non-prescribed NSAIDs that can worsen bleeding risk. Avoid raw or undercooked foods during neutropenia spikes. Correct any proven deficiencies (iron, B12, folate, vitamin D) under clinician guidance. Supplements should be discussed with your doctor to avoid interactions with immune-modifying drugs. Medscape

Frequently Asked Questions

Is ALPS genetic?
Often yes (FAS gene most common). Some cases are “somatic” (mutation only in some cells). PubMed
Why are my lymph nodes and spleen big?
Immune cells that should die stay alive and collect in nodes and spleen. MedlinePlus
What are “double-negative T cells”?
T cells missing CD4 and CD8; too many are a hallmark of ALPS. PMC
Can ALPS cause repeated viral infections (like EBV)?
Yes, immune imbalance and crowded cell populations can make some viral infections more frequent or persistent. PMC
What is the long-term risk?
There is an increased lymphoma risk; regular follow-up is important. PMC
Is sirolimus a common treatment now?
Yes, it often works when steroids fail and targets ALPS biology. PMC
Will I need my spleen removed?
Usually no; modern medicines reduced the need. Splenectomy is avoided if possible. Medscape
How is ALPS diagnosed?
History, exam, blood tests, high DNT cells, and genetic testing. PMC
Do all family members need testing?
Genetic counseling helps decide who to test. NCBI
What triggers hemolysis or low platelets?
Immune system attacks blood cells; infections can trigger flares. Medscape
Are live vaccines allowed?
Usually avoided during significant immunosuppression; follow specialist guidance. Medscape
Can diet cure ALPS?
No. Good nutrition supports health, but ALPS needs medical care. Medscape
Should I worry about EBV?
EBV can be persistent and is linked to some lymphoproliferative diseases; your team monitors for issues. PMC
Is HSCT a cure?
It can potentially cure the immune defect but is reserved for the most severe cases due to risks. Medscape
What specialists do I need?
Hematology and clinical immunology, with access to genetics and infectious diseases as needed. Medscape

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.